Susquehanna International Group
CABA icon

Susquehanna International Group’s Cabaletta Bio CABA Stock Holding History

Susquehanna International Group’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-138,281
Closed -$384K – 13220
2025
Q4 		$303K Sell
138,281
-233,827
-63% -$579K ﹤0.01% 9924
2025
Q3 		$871K Buy
372,108
+248,483
+201% +$426K ﹤0.01% 7672
2025
Q2 		$188K Buy
123,625
+65,845
+114% +$103K ﹤0.01% 11277
2025
Q1 		$80K Sell
57,780
-374,155
-87% -$797K ﹤0.01% 11674
2024
Q4 		$980K Buy
431,935
+408,583
+1,750% +$1.43M ﹤0.01% 6992
2024
Q3 		$110K Sell
23,352
-43,621
-65% -$252K ﹤0.01% 10992
2024
Q2 		$501K Buy
66,973
+2,874
+4% +$35.2K ﹤0.01% 8260
2024
Q1 		$1.09M Buy
64,099
+42,045
+191% +$902K ﹤0.01% 6676
2023
Q4 		$501K Buy
+22,054
New +$371K ﹤0.01% 8664
2023
Q2 		– Sell
-265,355
Closed -$2.88M – 12120
2023
Q1 		$2.19M Buy
265,355
+85,361
+47% +$799K ﹤0.01% 4940
2022
Q4 		$1.66M Sell
179,994
-85,375
-32% -$311K ﹤0.01% 5061
2022
Q3 		$173K Buy
265,369
+253,231
+2,086% +$305K ﹤0.01% 11051
2022
Q2 		$13K Sell
12,138
-15,609
-56% -$22.1K ﹤0.01% 12454
2022
Q1 		$56K Sell
27,747
-125,560
-82% -$328K ﹤0.01% 12259
2021
Q4 		$581K Buy
153,307
+95,376
+165% +$1.02M ﹤0.01% 8780
2021
Q3 		$704K Buy
57,931
+37,541
+184% +$346K ﹤0.01% 8488
2021
Q2 		$175K Buy
20,390
+1,689
+9% +$16.6K ﹤0.01% 11725
2021
Q1 		$208K Buy
+18,701
New +$228K ﹤0.01% 11356
2020
Q1 		– Sell
-12,458
Closed -$174K – 10259
2019
Q4 		$174K Buy
+12,458
New +$148K ﹤0.01% 8856

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Susquehanna International Group's CABA Position: Q1 2026 in Review

Susquehanna International Group sold out of Cabaletta Bio (CABA) in Q1 2026, closing a stake of 138,281 shares — an estimated $384K sold.

Susquehanna International Group first reported a position in CABA in Q4 2019 and held it in 19 quarters. The position peaked at $2.19M in Q1 2023. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

  • Susquehanna International Group reported no remaining Cabaletta Bio position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 138,281 Cabaletta Bio shares in Q1 2026, an estimated $384K.
  • Susquehanna International Group first reported a position in Cabaletta Bio in Q4 2019 and held it in 19 quarters.
  • Susquehanna International Group's Cabaletta Bio position peaked at $2.19M in Q1 2023.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.